Atlas Trials

Unresectable Endometrial Carcinoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Unresectable Endometrial Carcinoma

RecordFirmDate
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma (NCT05603910)Aaron Wolfson2023-04-15
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors (NCT05269381)Mayo Clinic2022-03-31
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661)National Cancer Institute (NCI)2021-08-09

Track Unresectable Endometrial Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.